Authors: Johnson, JL Okwera, A Hom, DL Mayanja, H Kityo, CM Nsubuga, P Nakibali, JG Loughlin, AM Yun, H Mugyenyi, PN Vernon, A Mugerwa, RD Ellner, JJ Whalen, CC

Citation: Jl. Johnson et al., Duration of efficacy of treatment of latent tuberculosis infection in HIV infected adults, AIDS, 15(16), 2001, pp. 2137-2147

Authors: Toossi, Z Mayanja-Kizza, H Hirsch, CS Edmonds, KL Spahlinger, T Hom, DL Aung, H Mugyenyi, P Ellner, JJ Whalen, CW

Citation: Z. Toossi et al., Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients, CLIN EXP IM, 123(2), 2001, pp. 233-238

Authors: Whalen, CC Nsubuga, P Okwera, A Johnson, JL Hom, DL Michael, NL Mugerwa, RD Ellner, JJ

Citation: Cc. Whalen et al., Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda, AIDS, 14(9), 2000, pp. 1219-1228

Authors: Guay, LA Hom, DL Kabengera, SR Piwowar-Manning, EM Kataaha, P Ndugwa, C Marum, LH Kalyesubula, I Jackson, JB

Citation: La. Guay et al., HIV-1ICD p24 antigen detection in Ugandan infants: Use in early diagnosis of infection and as a marker of disease progression, J MED VIROL, 62(4), 2000, pp. 426-434

Authors: Johnson, JL Kamya, RM Okwera, A Loughlin, AM Nyole, S Hom, DL Wallis, RS Hirsch, CS Wolski, K Foulds, J Mugerwa, RD Ellner, JJ

Citation: Jl. Johnson et al., Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis, J INFEC DIS, 181(4), 2000, pp. 1304-1312